DE502004008434D1 - 2- (HETERO) ARYL SUBSTITUTED TETRAHYDROCHINOLINE DERIVATIVES - Google Patents

2- (HETERO) ARYL SUBSTITUTED TETRAHYDROCHINOLINE DERIVATIVES

Info

Publication number
DE502004008434D1
DE502004008434D1 DE502004008434T DE502004008434T DE502004008434D1 DE 502004008434 D1 DE502004008434 D1 DE 502004008434D1 DE 502004008434 T DE502004008434 T DE 502004008434T DE 502004008434 T DE502004008434 T DE 502004008434T DE 502004008434 D1 DE502004008434 D1 DE 502004008434D1
Authority
DE
Germany
Prior art keywords
hetero
aryl substituted
tetrahydrochinoline
derivatives
tetrahydrochinoline derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE502004008434T
Other languages
German (de)
Inventor
Kai Schiemann
Ulrich Emde
Dirk Finsinger
Johannes Gleitz
Helmut Reubold
Frank Zenke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10360154A external-priority patent/DE10360154A1/en
Priority claimed from DE102004026026A external-priority patent/DE102004026026A1/en
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Priority claimed from PCT/EP2004/014205 external-priority patent/WO2005063735A1/en
Publication of DE502004008434D1 publication Critical patent/DE502004008434D1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/47064-Aminoquinolines; 8-Aminoquinolines, e.g. chloroquine, primaquine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4709Non-condensed quinolines and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4738Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • C07D491/044Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/052Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being six-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE502004008434T 2003-12-20 2004-12-14 2- (HETERO) ARYL SUBSTITUTED TETRAHYDROCHINOLINE DERIVATIVES Active DE502004008434D1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE10360154A DE10360154A1 (en) 2003-12-20 2003-12-20 New 2-(hetero)aryl-tetrahydroquinoline derivatives and 1,2,3,4-tetrahydro-1,5-naphthyridine derivatives are mitotic motor protein Eg5 inhibitors used as anticancer agents for treating carcinoma or leukemia
US53996104P 2004-01-30 2004-01-30
DE102004026026A DE102004026026A1 (en) 2004-05-27 2004-05-27 New 2-(hetero)aryl-tetrahydroquinoline derivatives and 1,2,3,4-tetrahydro-1,5-naphthyridine derivatives are mitotic motor protein Eg5 inhibitors used as anticancer agents for treating carcinoma or leukemia
PCT/EP2004/014205 WO2005063735A1 (en) 2003-12-20 2004-12-14 2-(hetero)-aryl-substituted tetrahydroquinoline derivatives

Publications (1)

Publication Number Publication Date
DE502004008434D1 true DE502004008434D1 (en) 2008-12-18

Family

ID=34743228

Family Applications (1)

Application Number Title Priority Date Filing Date
DE502004008434T Active DE502004008434D1 (en) 2003-12-20 2004-12-14 2- (HETERO) ARYL SUBSTITUTED TETRAHYDROCHINOLINE DERIVATIVES

Country Status (6)

Country Link
KR (1) KR101211973B1 (en)
AR (1) AR047068A1 (en)
CY (2) CY1110467T1 (en)
DE (1) DE502004008434D1 (en)
HK (1) HK1096395A1 (en)
MX (1) MXPA06006714A (en)

Also Published As

Publication number Publication date
MXPA06006714A (en) 2006-08-18
KR101211973B1 (en) 2012-12-13
CY1111704T1 (en) 2015-10-07
CY1110467T1 (en) 2015-04-29
KR20060127002A (en) 2006-12-11
HK1096395A1 (en) 2007-06-01
AR047068A1 (en) 2006-01-04

Similar Documents

Publication Publication Date Title
IS8348A (en) Synchronous heterocyclic compounds
SE0301569D0 (en) Novel compounds
DK1605897T3 (en) POLYETHELEN-GLYCOL-LINK-GLP-1 compounds
DK1531673T3 (en) Hitherto unknown 2-pyridylethylbenzamide derivative
IS8108A (en) New compounds
IS8439A (en) New quinoline derivatives
IS2656B (en) New besimidasol derivatives
IS8228A (en) New acetidine compounds
IS8089A (en) compounds
DK2275439T3 (en) Hitherto unknown insulin derivatives
IS8292A (en) New compounds
DE602004019555D1 (en) HETEROCYCLIC 7-AMINOALKYLIDENYLCHINOLONE AND -NAPHTHYRIDONE
IS7833A (en) Combined heterocyclic compounds
NO20070299L (en) Novel heterocyclic compounds
ATE354365T1 (en) N-THIAZOLE-2-YL-BENZAMIDE DERIVATIVES
DE602004007387D1 (en) 5-SUBSTITUTED CHINAZOLINONE DERIVATIVES
DK1667975T3 (en) A polymorphic form of 3-phenylsulfonyl-8-piperazin-1-yl-quinoline
NO20054141D0 (en) Substituted 2- (diaza-bicycloalkyl) pyrimidone derivatives
NO20055097D0 (en) Crystalline N-formyl-hydroxylamine compounds
DE502004008434D1 (en) 2- (HETERO) ARYL SUBSTITUTED TETRAHYDROCHINOLINE DERIVATIVES
NO20031736D0 (en) compounds
FI114761B (en) Temperature compensated amplifier
SE0203606D0 (en) Heterocyclic compounds
DE60334703D1 (en) HETEROCYCLIC DERIVATIVES
ATE360010T1 (en) HETEROCYCLIC RETIOID COMPOUNDS

Legal Events

Date Code Title Description
8364 No opposition during term of opposition